Polypharmacy Action Learning Sets - April 2023 to March 2024
Published 25/05/2023
Action Learning Set workshops - LIMITED SPACES
The East Midlands AHSN polypharmacy programme invites you to join our Action Learning Sets (ALS) to help build GP and prescribing health care professionals' confidence in, and understanding of, the complex issues surrounding stopping inappropriate medicines safely.
Who are they for:
Any prescriber in primary care with at least 12 months prescribing experience and who prescribes and reviews medication regularly.
How long is the training:
Three sessions each lasting three hours, delivered virtually. Delegates need to attend all three sessions.
How much does it cost to register:
Free to prescribers.
Alternatively you can contact richardmcbain@nottingham.ac.uk
Polypharmacy: getting the balance right
Background
Almost a million people in the UK receive 10 or more medicines to take regularly for their long- term conditions, and almost 400,000 of these people are aged 75 and over. Whilst medicines have undoubtedly helped many millions of people, taking numerous medicines can tip the balance between risk and benefit. This is commonly called problematic polypharmacy.
Programme aim
To “support local systems and primary care to identify patients at potential risk of harm and support better conversations about medicines by promoting shared decision making”.
The Programme
There programme comprises 3 pillars (see below) that focus on a different element to provide comprehensive coverage for improving polypharmacy. The programme is also underpinned by an East Midlands wide Community of Practice which brings together key stakeholders from all sectors to share solutions and address challenges to problematic polypharmacy.
Pillar 1: Population Health Management
The NHS Business Service Authority provides polypharmacy prescribing data by practice, PCN and ICS, and allows identification of patients at the greatest risk of harm from polypharmacy.
Pillar 2: Education and Training
Our Polypharmacy Action Learning Sets (ALS) have been shown to improve the confidence of GPs and independent prescribers in undertaking shared decision-making as part of a multimorbidity medication review.
Pillar 3: Public Behaviour Change
Supports patient empowerment about their medicines using behaviour change models. Encouraging patients to share their issues, concerns and expectations about the medicines that have been prescribed for them.
Alternatively you can contact richardmcbain@nottingham.ac.uk
Tagged as: Training
Share this post: